Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl ester as ATP-competitive inhibitors of BRAF: A bioinformatics study.

ATP-Competitive inhibitors and cancer BRAF BRAF V600E mutant Caffeic acid phenethyl ester Withaferin-A Withanone

Journal

Current research in structural biology
ISSN: 2665-928X
Titre abrégé: Curr Res Struct Biol
Pays: Netherlands
ID NLM: 101767537

Informations de publication

Date de publication:
2021
Historique:
received: 02 03 2021
revised: 09 11 2021
accepted: 10 11 2021
entrez: 14 1 2022
pubmed: 15 1 2022
medline: 15 1 2022
Statut: epublish

Résumé

Serine/threonine-protein kinase B-raf (BRAF) plays a significant role in regulating cell division and proliferation through MAPK/ERK pathway. The constitutive expression of wild-type BRAF (BRAF

Identifiants

pubmed: 35028596
doi: 10.1016/j.crstbi.2021.11.004
pii: S2665-928X(21)00027-1
pmc: PMC8714769
doi:

Types de publication

Journal Article

Langues

eng

Pagination

301-311

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Int J Mol Sci. 2019 Oct 25;20(21):
pubmed: 31731424
Nat Commun. 2020 Sep 1;11(1):4370
pubmed: 32873792
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
Mol Cancer Ther. 2015 Oct;14(10):2187-97
pubmed: 26208524
Pharmaceutics. 2020 May 24;12(5):
pubmed: 32456290
Cancers (Basel). 2020 Jul 07;12(7):
pubmed: 32645969
Oncotarget. 2019 Nov 12;10(61):6623-6640
pubmed: 31762942
Mol Cancer Ther. 2014 Dec;13(12):2930-40
pubmed: 25236891
Crit Rev Oncol Hematol. 2017 Dec;120:52-59
pubmed: 29198338
Cell. 2004 Mar 19;116(6):855-67
pubmed: 15035987
Biomolecules. 2021 Jan 26;11(2):
pubmed: 33530424
Int J Mol Sci. 2019 Mar 25;20(6):
pubmed: 30934534
Cancers (Basel). 2019 Mar 30;11(4):
pubmed: 30934990
Bioinformatics. 2016 Dec 1;32(23):3676-3678
pubmed: 27503228
Nat Rev Cancer. 2014 Jul;14(7):455-67
pubmed: 24957944
Cancer Sci. 2017 Jul;108(7):1368-1377
pubmed: 28445002
Antioxidants (Basel). 2020 May 05;9(5):
pubmed: 32380762
Am J Surg. 2012 Dec;204(6):895-900; discussion 900-1
pubmed: 23231932
ACS Chem Biol. 2016 Oct 21;11(10):2876-2888
pubmed: 27571413
J Nat Prod. 2016 Mar 25;79(3):629-61
pubmed: 26852623
Mol Cancer Ther. 2006 Jun;5(6):1434-45
pubmed: 16818501
Recent Prog Horm Res. 2001;56:127-55
pubmed: 11237210
Cancers (Basel). 2019 Sep 18;11(9):
pubmed: 31540406
J Nat Prod. 2020 Mar 27;83(3):770-803
pubmed: 32162523
J Transl Med. 2012 Jul 09;10:85
pubmed: 22554099
PLoS One. 2010 Oct 21;5(10):e13536
pubmed: 20975835
Cancer Lett. 2011 Sep 1;308(1):43-53
pubmed: 21570765
Ann Transl Med. 2015 Sep;3(15):207
pubmed: 26488003
Drugs. 2018 Aug;78(12):1277-1284
pubmed: 30117021
Cancer Cell. 2014 Sep 8;26(3):402-413
pubmed: 25155755
Eur Rev Med Pharmacol Sci. 2012 Dec;16(15):2064-8
pubmed: 23280020
PLoS One. 2015 Jul 31;10(7):e0134137
pubmed: 26230090
Cancer Res. 2011 Dec 1;71(23):7137-40
pubmed: 22131348
J Chem Theory Comput. 2021 Oct 12;17(10):6491-6508
pubmed: 34506133
PLoS One. 2013 Jul 03;8(7):e67583
pubmed: 23844038
Drugs. 2013 Aug;73(12):1367-76
pubmed: 23881668
J Chem Theory Comput. 2019 Mar 12;15(3):1863-1874
pubmed: 30768902
Clin Cancer Res. 2017 Sep 15;23(18):5339-5348
pubmed: 28611198
Drug Des Devel Ther. 2017 Jun 22;11:1859-1870
pubmed: 28694686
Int J Mol Sci. 2021 Aug 24;22(17):
pubmed: 34502041
Expert Opin Drug Discov. 2015 May;10(5):449-61
pubmed: 25835573
Int J Biol Macromol. 2021 Aug 1;184:297-312
pubmed: 34118289
Elife. 2015 Jul 20;4:e07454
pubmed: 26193119
BMC Cancer. 2013 Jan 14;13:17
pubmed: 23317446
Mol Cell Biol. 2015 Jan;35(1):264-76
pubmed: 25348715
J Clin Oncol. 2020 Jul 1;38(19):2140-2150
pubmed: 32182156
Cell Death Dis. 2017 Apr 20;8(4):e2755
pubmed: 28425984
Nat Prod Bioprospect. 2021 Feb;11(1):5-13
pubmed: 33389713
Drugs. 2018 Apr;78(5):549-566
pubmed: 29488071
Cancers (Basel). 2020 May 05;12(5):
pubmed: 32380701
Nat Rev Cancer. 2017 Nov;17(11):676-691
pubmed: 28984291
Methods Mol Biol. 2008;443:63-88
pubmed: 18446282
Onco Targets Ther. 2019 Jan 18;12:635-645
pubmed: 30705592
J Mol Graph Model. 2013 Nov;46:41-51
pubmed: 24121518

Auteurs

Vidhi Malik (V)

DAILAB, Department of Biochemical Engineering & Biotechnology, Indian Institute of Technology (IIT)-Delhi, Hauz Khas, New Delhi, 110-016, India.

Vipul Kumar (V)

DAILAB, Department of Biochemical Engineering & Biotechnology, Indian Institute of Technology (IIT)-Delhi, Hauz Khas, New Delhi, 110-016, India.

Sunil C Kaul (SC)

AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, 305-8565, Japan.

Renu Wadhwa (R)

AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, 305-8565, Japan.

Durai Sundar (D)

DAILAB, Department of Biochemical Engineering & Biotechnology, Indian Institute of Technology (IIT)-Delhi, Hauz Khas, New Delhi, 110-016, India.

Classifications MeSH